[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Muhammad Aamir Latif\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":193},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,8,0,[8,41,65,81,106,128,150,172],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":18,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":23,"briefSummary":25,"conditions":26,"keywords":4,"overallStatus":28,"whyStopped":4,"lastUpdateSubmitDate":29,"lastUpdatePostDateStruct":30,"startDateStruct":33,"completionDateStruct":35,"leadSponsor":37,"locationsCount":40},"100640015","volar-locking-plate-comparison-with-external-fixator-100640015",false,"NCT07576075","Volar Locking Plate Comparison With External Fixator","Comparison of the Outcomes of Volar Locking Plate Versus External Fixator in Distal Intra-articular Radius Fractures.","Inclusion Criteria:\n\n* Any gender\n* Aged 20 to 60\n* with intra-articular fractures of the distal radius\n* The fracture lasted less than seven days\n\nExclusion Criteria:\n\n* Patients with bilateral distal radius fractures and any further related injuries or fractures\n* Distal radius open fractures\n* Individuals receiving immunosuppressive, chemotherapeutic, or corticosteroid medications (based on medical history and records)\n* Individuals with underlying medical co-morbidities, such as diabetes and uncontrolled hypertension, (determined by their medical history and record)","ALL","20 Years","60 Years",{"count":20,"type":21},60,"ESTIMATED","INTERVENTIONAL",[24],"NA","Local data has shown conflicting results regarding the outcomes of volar locking plates versus external fixators in distal intra-articular radius fractures. Therefore, the current study was planned with the objective of comparing the outcome of a volar locking plate versus an external fixator in distal intra-articular radius fractures.",[27],"Articular Fracture","RECRUITING","2026-05-04",{"date":31,"type":32},"2026-05-08","ACTUAL",{"date":34,"type":32},"2025-10-05",{"date":36,"type":21},"2026-06-30",{"name":38,"class":39},"Muhammad Aamir Latif","OTHER",1,{"id":42,"slug":43,"hasResults":11,"nctId":44,"briefTitle":45,"officialTitle":46,"acronym":4,"eligibilityCriteria":47,"healthyVolunteers":11,"sex":16,"minAge":48,"maxAge":49,"enrollmentInfo":50,"targetDuration":4,"studyType":52,"phases":4,"briefSummary":53,"conditions":54,"keywords":4,"overallStatus":28,"whyStopped":4,"lastUpdateSubmitDate":56,"lastUpdatePostDateStruct":57,"startDateStruct":59,"completionDateStruct":61,"leadSponsor":63,"locationsCount":64},"100636134","comparison-of-surgical-blade-no-11-and-ophthalmic-knife-in-idiopathic-clubfoot-patients-100636134","NCT07561736","Comparison of Surgical Blade No. 11 and Ophthalmic Knife in Idiopathic Clubfoot Patients","Comparison of Effectiveness of Surgical Blade No. 11 and Ophthalmic Knife for Percutaneous Achilles Tendon Tenotomy in Idiopathic Clubfoot Patients","Inclusion Criteria:\n\n* Any gender\n* Aged 2-5 years\n* Diagnosed with clubfoot\n\nExclusion Criteria:\n\n* Children with other neuromuscular\n* Chromosomal abnormalities\n* Arthrogryposis multiplex congenita\n* Myelomeningocele\n* Dystrophic dysplasia\n* Moebius syndrome\n* Amniotic band syndrome\n* Metatarsus adductus\n* Syndactyly\n* Polydactyly","2 Years","5 Years",{"count":51,"type":21},102,"OBSERVATIONAL","There is limited local data available on the comparison between surgical blade no.11 and ophthalmic knife among patients with neglected clubfoot going through tenotomy. The study has been planned with the objective of comparing the effectiveness of surgical blade no. 11 and ophthalmic knife for percutaneous Achilles tendon tenotomy in Idiopathic clubfoot patients",[55],"Clubfoot","2026-04-24",{"date":58,"type":32},"2026-05-01",{"date":60,"type":32},"2025-09-20",{"date":62,"type":21},"2026-04-30",{"name":38,"class":39},2,{"id":66,"slug":67,"hasResults":11,"nctId":68,"briefTitle":69,"officialTitle":70,"acronym":4,"eligibilityCriteria":71,"healthyVolunteers":11,"sex":16,"minAge":48,"maxAge":49,"enrollmentInfo":72,"targetDuration":4,"studyType":52,"phases":4,"briefSummary":74,"conditions":75,"keywords":4,"overallStatus":28,"whyStopped":4,"lastUpdateSubmitDate":56,"lastUpdatePostDateStruct":76,"startDateStruct":77,"completionDateStruct":79,"leadSponsor":80,"locationsCount":40},"100636131","percutaneous-achilles-tendon-tenotomy-vs-tendo-achilles-lengthening-tal-in-neglected-clubfoot-children-100636131","NCT07561697","Percutaneous Achilles Tendon Tenotomy vs Tendo-Achilles Lengthening (TAL) in Neglected Clubfoot Children.","Functional Outcomes of Percutaneous Achilles Tendon Tenotomy vs Tendo-Achilles Lengthening (TAL) in Neglected Clubfoot Children Age 2-5 Years.","Inclusion Criteria:\n\n* Any gender\n* Aged 2-5 years\n* diagnosed with clubfoot\n* Pirani score 3-6\n\nExclusion Criteria:\n\n* Patients with other neuromuscular, chromosomal abnormalities\n* myelomeningocele\n* Dystrophic dysplasia\n* Moebius syndrome\n* Amniotic band syndrome\n* Metatarsus adductus\n* Syndactyly\n* Polydactyly\n* Previously underwent Achilles tendon tenotomy or tendo-Achilles lengthening",{"count":73,"type":21},44,"Achilles tendon tenotomy is the established worldwide gold standard for correcting idiopathic clubfoot. However, in neglected cases, surgical interventions such as percutaneous Achilles tendon tenotomy (PAT) and open tendo-Achilles lengthening (TAL) are common techniques for correcting this deformity. This study aimed at determining the functional outcomes of Percutaneous Achilles Tendon Tenotomy (PAT) vs tendo-Achilles Lengthening (TAL) in the neglected clubfoot children of age 2-5 years.",[55],{"date":58,"type":32},{"date":78,"type":32},"2025-08-15",{"date":62,"type":21},{"name":38,"class":39},{"id":82,"slug":83,"hasResults":11,"nctId":84,"briefTitle":85,"officialTitle":86,"acronym":4,"eligibilityCriteria":87,"healthyVolunteers":11,"sex":88,"minAge":89,"maxAge":90,"enrollmentInfo":91,"targetDuration":4,"studyType":22,"phases":93,"briefSummary":94,"conditions":95,"keywords":4,"overallStatus":97,"whyStopped":4,"lastUpdateSubmitDate":98,"lastUpdatePostDateStruct":99,"startDateStruct":101,"completionDateStruct":103,"leadSponsor":105,"locationsCount":40},"100628480","impact-of-enoxaparin-therapy-on-fetal-outcomes-in-intrauterine-growth-restriction-100628480","NCT07462182","Impact of Enoxaparin Therapy on Fetal Outcomes in Intrauterine Growth Restriction","Impact of Enoxaparin Therapy on Fetal Outcomes in Intrauterine Growth Restriction With Oligohydramnios.","Inclusion Criteria:\n\n* Women aged 18-40 years\n* Singleton pregnancy\n* Gestational age ≥28 weeks (confirmed by first-trimester scan or reliable last menstrual period)\n* Diagnosed with both IUGR and oligohydramnios\n* Willing to provide informed written consent\n\nExclusion Criteria:\n\n* Multiple gestation\n* Major fetal congenital anomalies\n* Maternal medical disorders affecting pregnancy outcome (e.g., uncontrolled diabetes, chronic hypertension, renal disease)\n* Known coagulation disorders or contraindications to enoxaparin\n* Women already on anticoagulation therapy.","FEMALE","18 Years","40 Years",{"count":92,"type":21},108,[24],"The local literature lacks comprehensive information regarding the actual incidence of intrauterine growth restriction (IUGR) and oligohydramnios and currently available therapeutic options. Therefore, the current study was planned with the objective to evaluate the impact of enoxaparin therapy compared with standard management on neonatal outcomes in pregnancies complicated by intrauterine growth restriction (IUGR) with oligohydramnios.",[96],"Intrauterine Growth Restriction","NOT_YET_RECRUITING","2026-03-04",{"date":100,"type":32},"2026-03-10",{"date":102,"type":21},"2026-04-01",{"date":104,"type":21},"2026-09-30",{"name":38,"class":39},{"id":107,"slug":108,"hasResults":11,"nctId":109,"briefTitle":110,"officialTitle":111,"acronym":4,"eligibilityCriteria":112,"healthyVolunteers":11,"sex":16,"minAge":113,"maxAge":114,"enrollmentInfo":115,"targetDuration":4,"studyType":22,"phases":117,"briefSummary":118,"conditions":119,"keywords":4,"overallStatus":28,"whyStopped":4,"lastUpdateSubmitDate":121,"lastUpdatePostDateStruct":122,"startDateStruct":124,"completionDateStruct":126,"leadSponsor":127,"locationsCount":40},"100626573","effect-of-l-carnitine-supplementation-in-preterm-neonates-100626573","NCT07437391","Effect of L-Carnitine Supplementation in Preterm Neonates","Effect of L-Carnitine Supplementation in Preterm Neonates Suffering From Respiratory Distress Syndrome (RDS)","Inclusion Criteria:\n\n* Preterm neonates\n* Either gender\n* With RDS\n* Admitted to the neonatal intensive care unit (NICU) within 24 hours of birth .\n\nExclusion Criteria:\n\n* Neonates with gastrointestinal tract (GIT) anomalies\n* With confirmed or suspected sepsis at the time of enrollment\n* Neonates whose clinical condition contraindicates study participation (e.g., expected survival \\\u003C48 hours, as judged by the neonatologist).","1 Hour","24 Hours",{"count":116,"type":21},160,[24],"The current study is planned to see the effect of L-carnitine supplementation in preterm neonates suffering from RDS among the local population, as there is no such evidence available for the local population and there are conflicting statistics regarding the discharge rate of these neonates.",[120],"Respiratory Distress Syndrome","2026-02-23",{"date":123,"type":32},"2026-02-27",{"date":125,"type":32},"2026-01-01",{"date":36,"type":21},{"name":38,"class":39},{"id":129,"slug":130,"hasResults":11,"nctId":131,"briefTitle":132,"officialTitle":133,"acronym":4,"eligibilityCriteria":134,"healthyVolunteers":11,"sex":16,"minAge":135,"maxAge":136,"enrollmentInfo":137,"targetDuration":4,"studyType":22,"phases":139,"briefSummary":140,"conditions":141,"keywords":4,"overallStatus":97,"whyStopped":4,"lastUpdateSubmitDate":143,"lastUpdatePostDateStruct":144,"startDateStruct":145,"completionDateStruct":147,"leadSponsor":149,"locationsCount":40},"100625754","antipyretic-therapy-with-and-without-cold-sponging-100625754","NCT07426744","Antipyretic Therapy With and Without Cold Sponging","Antipyretic Therapy With and Without Cold Sponging: A Comparative Study in Febrile Children.","Inclusion Criteria:\n\n* Children of either gender\n* Aged 6 to 60 months.\n* Presenting with a fever (an axillary or oral temperature \\>38.0°C)\n* No use of paracetamol or other antipyretics within the past 6 hours. 4. Parental\u002Fguardian giving informed written consent.\n\nExclusion Criteria:\n\n* Children with chronic systematic conditions (e.g., congenital heart defects, renal or respiratory diseases)\n* History of febrile seizures or other seizure disorders\n* Known hypersensitivity or contraindication to paracetamol\n* Presence of dermatological conditions that may aggravate by sponging (eg., eczema, contact dermatitis, psoriasis, skin infection, xerosis)","6 Months","60 Months",{"count":138,"type":21},210,[24],"This study aims to fill the gaps regarding the effectiveness of paracetamol alone with paracetamol combined with cold sponging in febrile children.",[142],"Fever","2026-02-16",{"date":121,"type":32},{"date":146,"type":21},"2026-03-01",{"date":148,"type":21},"2026-08-31",{"name":38,"class":39},{"id":151,"slug":152,"hasResults":11,"nctId":153,"briefTitle":154,"officialTitle":155,"acronym":4,"eligibilityCriteria":156,"healthyVolunteers":11,"sex":16,"minAge":157,"maxAge":158,"enrollmentInfo":159,"targetDuration":4,"studyType":22,"phases":160,"briefSummary":161,"conditions":162,"keywords":4,"overallStatus":28,"whyStopped":4,"lastUpdateSubmitDate":164,"lastUpdatePostDateStruct":165,"startDateStruct":167,"completionDateStruct":169,"leadSponsor":171,"locationsCount":40},"100620169","comparative-efficacy-of-flunarizine-and-propanolol-in-pediatric-migraine-100620169","NCT07354126","Comparative Efficacy of Flunarizine and Propanolol in Pediatric Migraine","Comparative Efficacy of Flunarizine and Propanolol in Pediatric Migraine Using the PedMIDAS Measuring Tool.","Inclusion Criteria:\n\n* Children of any gender\n* Aged 8-15 years\n* Diagnosed with migraine (with\u002Fwithout aura) per International Classification of Headache Disorders, 3rd Edition (ICHD-3) criteria\n* A history of ≥4 migraine attacks\u002Fmonth for the preceding 3 months\n* With a PedMIDAS score ≥11 (moderate-to-severe impact)\n\nExclusion Criteria:\n\n* Children with secondary headache disorders (e.g., due to infections, trauma, structural brain lesions)\n* Known hypersensitivity or contraindications to flunarizine or propranolol\n* Presence of cardiovascular disorders (e.g., bradycardia, heart block, hypotension, asthma)\n* Non-compliance or inability to attend regular follow-ups\n* Participation in another clinical trial within the last 3 months","8 Years","15 Years",{"count":73,"type":21},[24],"Flunarizine and propranolol have demonstrated efficacy in reducing migraine frequency across age groups, though evidence in pediatric populations remains limited and inconsistent. Therefore, the current study has been planned to evaluate and compare the effectiveness of flunarizine and propranolol in reducing migraine frequency in children aged 8-15 using the Pediatric Migraine Disability Assessment Scale (PedMIDAS) score.",[163],"Migraine","2026-01-12",{"date":166,"type":32},"2026-01-21",{"date":168,"type":32},"2025-09-01",{"date":170,"type":21},"2026-02-28",{"name":38,"class":39},{"id":173,"slug":174,"hasResults":11,"nctId":175,"briefTitle":176,"officialTitle":177,"acronym":4,"eligibilityCriteria":178,"healthyVolunteers":11,"sex":88,"minAge":89,"maxAge":90,"enrollmentInfo":179,"targetDuration":4,"studyType":22,"phases":181,"briefSummary":182,"conditions":183,"keywords":4,"overallStatus":97,"whyStopped":4,"lastUpdateSubmitDate":185,"lastUpdatePostDateStruct":186,"startDateStruct":188,"completionDateStruct":190,"leadSponsor":192,"locationsCount":40},"100589082","to-compare-sweeping-of-membranes-versus-expectant-management-for-spontaneous-onset-of-labor-and-vaginal-delivery-100589082","NCT06949787","To Compare Sweeping of Membranes Versus Expectant Management for Spontaneous Onset of Labor and Vaginal Delivery.","Comparison of Spontaneous Onset of Labor and Vaginal Delivery in Post-date Primigravida Undergoing Sweeping of Membranes Versus Expectant Management","Inclusion Criteria:\n\n* Primigravid women\n* Aged between 18 and 40 years\n* Gestational age ≥40 weeks, confirmed by ultrasound or early dating scan\n* Singleton pregnancies\n* Cephalic presentation\n\nExclusion Criteria:\n\n* Multiple gestations\n* Fetal distress or anomalies detected on ultrasound\n* Contraindications to vaginal delivery (e.g., placenta previa, previous uterine surgery)\n* Previous uterine scar",{"count":180,"type":21},132,[24],"The study is planned to fill the gaps regarding the effectiveness of sweeping of membranes versus expectant management in terms of spontaneous onset of labor and vaginal delivery in post-date primigravida.",[184],"Post-Term Pregnancy","2025-04-22",{"date":187,"type":32},"2025-04-29",{"date":189,"type":21},"2025-05-01",{"date":191,"type":21},"2025-10-31",{"name":38,"class":39},""]